Log In or Register to Join The Conversation!
Viewing 0 reply threads
  • Author
    Posts
    • #11002

      With the approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing multiple sclerosis (MS), interest in the medication is peaking. To help readers of Multiple Sclerosis News Today better understand this new medication and how it works, as well as issues dealing with access, use, and potential side effects, here is a summary of the most relevant information now available about Ocrevus.

      Comments and concerns expressed by many readers on our different platforms were taken into consideration in writing this article.

      The basics
      Ocrevus is a prescription medication, so people considering the treatment should discuss with their physicians whether it may be suitable for them.

      Genentech — Ocrevus’s developer — is working to make sure that patients receive adequate information about the therapy. The company has set up a website — http://www.ocrevus.com — with detailed information. Patients can also call 1-844-627-3887 (Ocrevus Connects, Monday to Friday, from 9 am to 8 pm ET) with questions concerning this therapy.

      Read more about Ocrevus here: “What Every MS Patient Should Know About Ocrevus and Its Use

      Have you tried (or know someone who’s tried) this treatment? Share your experience below.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account